RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors
- PMID: 28040596
- DOI: 10.1016/j.biopha.2016.12.071
RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors
Retraction in
-
Retraction notice to "Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors" [Biomed. Pharmacother. 87 (2017) 37-45].Biomed Pharmacother. 2017 Dec;96:1570. doi: 10.1016/j.biopha.2017.07.062. Epub 2017 Jul 21. Biomed Pharmacother. 2017. PMID: 28739296 No abstract available.
Abstract
Myocardial infarction has been reported to be responsible for about 7.3 million deaths each year globally. Present treatments for myocardial infarction have been more palliative rather than curative. Over the past few years, stem cells have demonstrated its potency in regenerating damaged cardiac tissue, especially after myocardial infarction. However, limited short half-life of the protein and cell therapy and low transplanted cell survival rate as demonstrated via several clinical trials have lead to development of more potent and novel delivery systems like biomaterial delivery system and the use of various growth factors. In this review, we will be enumerating and discussing the recent advances in cardiac regeneration with focus on stem cell, biomaterial and growth factors.
Keywords: Biomaterials; Cell therapy; Delivery systems; Myocardial infarction; Protein therapy.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Heart regeneration after myocardial infarction using synthetic biomaterials.J Control Release. 2015 Apr 10;203:23-38. doi: 10.1016/j.jconrel.2015.02.009. Epub 2015 Feb 7. J Control Release. 2015. PMID: 25665866 Review.
-
Endogenous cardiac stem cells.Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):31-48. doi: 10.1016/j.pcad.2007.03.005. Prog Cardiovasc Dis. 2007. PMID: 17631436 Review.
-
The heart's content-renewable resources.Int J Cardiol. 2013 Aug 20;167(4):1141-6. doi: 10.1016/j.ijcard.2012.09.051. Epub 2012 Oct 6. Int J Cardiol. 2013. PMID: 23044434 Review.
-
Cardiac stem cell therapy: review of the native cardiac progenitor cells and future direction.J Cardiovasc Pharmacol. 2014 Feb;63(2):85-94. doi: 10.1097/FJC.0b013e318299ebc0. J Cardiovasc Pharmacol. 2014. PMID: 23674056 Review.
-
The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away.Circ Res. 2017 Jan 20;120(2):400-406. doi: 10.1161/CIRCRESAHA.116.309710. Circ Res. 2017. PMID: 28104772 Free PMC article. Review.
Cited by
-
Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration.Stem Cells Int. 2018 Apr 29;2018:3123961. doi: 10.1155/2018/3123961. eCollection 2018. Stem Cells Int. 2018. PMID: 29853910 Free PMC article. Review.
-
Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases.Front Bioeng Biotechnol. 2020 Mar 31;8:251. doi: 10.3389/fbioe.2020.00251. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32296694 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous